Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Therapeutic Solutions International Inc
(OP:
TSOI
)
0.0006
-0.0001 (-14.29%)
Streaming Delayed Price
Updated: 3:56 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Therapeutic Solutions International Inc
< Previous
1
2
3
Next >
Therapeutic Solutions International Receives Notice of Allowance for Landmark Patent Covering Cellular Therapy of Lung Diseases
May 16, 2024
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Immunology Based Suicide Prevention Company Campbell Neurosciences Announces Appointment of Public Company Veteran Raymond Oliver as Chairman of the Board
May 09, 2024
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Therapeutic Solutions International Granted Patent on Commercially Available QuadraMune® Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 Patients
March 04, 2024
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Therapeutic Solutions International Announces Landmark Finding Regarding Mechanism of Action of its JadiCell Stem Cell Product
February 29, 2024
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Therapeutic Solutions International Files Lawsuit in San Diego Superior Court to Obtain Identities of Certain Individuals or Entities
January 22, 2024
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Therapeutic Solutions International Launches Adult Stem Cell Therapy Company Focused on Curing Epilepsy
January 16, 2024
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Therapeutic Solutions International Subsidiary Immunotherapy Company Res Nova Bio, Inc. Announces Positive Data on First Four Advanced Cancer Patients Treated with FloraStilbene™
January 03, 2024
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Therapeutic Solutions International Announces Formation of ALS Biologics Inc to Commercialize Regenerative Technologies Related to Dreaded Motor Neuron Disease
December 11, 2023
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Therapeutic Solutions International and Campbell Neurosciences Publish on Nutritional Modulation of the Indolamine 2,3 Dioxygenase Pathway as a Non-Toxic Means of Addressing Depression
November 27, 2023
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Therapeutic Solutions International Collaborates on Peer-Reviewed Publication on Personalized Immunotherapy for Brain Cancer Using mRNA
November 20, 2023
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Res Nova Biologics Announces First Cancer Patient Treated with FloraStilbene™
October 20, 2023
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Res Nova Biologics Recruits Abortion Pill Reversal Founder to Scientific Advisory Board
October 17, 2023
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Therapeutic Solutions International Announces Paradigm Shifting Immunotherapy Product: Tolerogenic Neutrophils
September 29, 2023
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Therapeutic Solutions International Recruits Internationally Renowned Stem Cell Clinician and San Diego Top Doctor to Scientific Advisory Board
September 18, 2023
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Therapeutic Solutions International Subsidiary Discloses Potential Solution to Immunotherapy Resistance in Cancer by “Healing Tumor” Before Killing It
September 15, 2023
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Therapeutic Solutions International Reports Landmark Advancement in Stem Cell Therapy of Frontotemporal Dementia
September 11, 2023
From
Therapeutic Solutions International, Inc.
Via
Business Wire
FloraStilbene™ Demonstrates Synergy with Conventional Chemotherapy and Immunotherapy in Reducing Triple Negative Breast Cancer
August 21, 2023
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Therapeutic Solutions International Subsidiary Allogen Biologics Inc. Successfully Manufactures JadiCell Master Cell Bank to Provide Cells for Right to Try Use and Phase III ARDS Clinical Trial
August 16, 2023
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Therapeutic Solutions International Prevention Subsidiary Campbell Neurosciences Receives Notice of Allowance on Suicide Prevention Drug Candidate
July 31, 2023
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Therapeutic Solutions International Subsidiary Res Nova Bio Inc Discovers New Mechanism of Action for Breast Cancer Immunotherapy Adjuvant FloraStilbene™
July 18, 2023
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Therapeutic Solutions International Files for Orphan Drug Designation Use of JadiCell Adult Stem Cells for Treatment of Frontotemporal Dementia
July 12, 2023
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Therapeutic Solutions International Files for Orphan Drug Designation Using JadiCell Adult Universal Donor Stem Cells for Treatment of Acute Respiratory Distress Syndrome
June 26, 2023
From
Therapeutic Solutions International
Via
Business Wire
Therapeutic Solutions International Launches Subsidiary Company to Commercialize Clinical Data and IND for Treatment of Chronic Traumatic Encephalopathy (CTE) with JadiCell Universal Adult Stem Cells
May 25, 2023
From
Therapeutic Solutions International
Via
Business Wire
Therapeutic Solutions International Spin-Off Res Nova Bio Leverages FDA Cleared Tumor Blood Vessel Targeting Technology to Intravenously Deliver Cancer Killing Viruses
May 22, 2023
From
Therapeutic Solutions International
Via
Business Wire
Therapeutic Solutions International Spin-Off Res Nova Bio Partners with Cure Stat Rx to Manufacture First in Class Breast Cancer Immunotherapy Product FloraStilbene™
May 15, 2023
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Therapeutic Solutions International Launches VasoSome Vascular Inc Based on Successful Treatment of Aortic Aneurysms using Patent Pending Exosome Therapy
May 01, 2023
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Therapeutic Solutions International Files to Initiate Phase III Clinical Trial for Acute Respiratory Distress Syndrome (ARDS) Leveraging Positive COVID-19 Data with JadiCell Stem Cell Therapy
April 20, 2023
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Therapeutic Solutions International Spin Off Campbell Neurosciences Announces Novel Mechanistic Data on CampbellCell Stem Cell Therapy for Schizophrenia
April 03, 2023
From
Therapeutic Solutions International, Inc.
Via
Business Wire
Biotechnology Veteran Dr. Thomas Ichim to Lead Suicide Prediction Company Campbell Neurosciences, Inc.
March 27, 2023
From
Therapeutic Solutions International
Via
Business Wire
Therapeutic Solutions International Spin Off Campbell Neurosciences Creates Saliva Based Test for Suicidal Ideations
March 20, 2023
From
Therapeutic Solutions International
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.